Medipharm Internationalsp. z o.o. + limited partnership
Wholesale of chemical products
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2014-05-27
Limited partner contribution
6,000.00 PLN
Registered address
Emilii Sczanieckiej 20B, 64-316 Kuślin, Poland
Electronic delivery address
AE:PL-36391-22669-DHWRU-31
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 44 days early.
- 202529/05/2026
- 202417/06/2025
- 202314/06/2024
- 202207/06/2023
- 202111/07/2022
- 202024/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 167.35kMedianUSD 895.43kAverageUSD 9.80m
Net profit
This companyUSD -4.18kMedianUSD 19.07kAverageUSD 341.02k
Operating costs
This companyUSD 162.49kMedianUSD 832.62kAverageUSD 8.90m
Assets
This companyUSD 215.08kMedianUSD 474.63kAverageUSD 5.34m
Industry
Partners
| Partners | Partner role |
|---|---|
Józef Napierałaage 77 | Limited partner |
Aleksandra Maria Dobrzyńskaage 52 | General partner |
| General partner |
Manner of representation
The company is represented by the general partner – Medipharm International spółka z ograniczoną odpowiedzialnością, acting through the management board.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-12-29.
07 1090 1346 0000 0001 5863 8340
31 1090 1346 0000 0001 5863 8296
16 1090 1388 0000 0001 4276 2009
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $8,792.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 22, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $6,154$6,154 | Polski Fundusz Rozwoju S.A. | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $698$698 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Starosta Powiatu Nowy Tomyśl |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| AD System Żebrowskisp. k. | $7,625,910.85 | adsystem.com.pl | ||
| Provital Polskasp. z o.o. | $5,805,102.40 | weareprovital.com | ||
| Przedsiębiorstwo Handlowo - Usługowe Agrarsp. z o.o. | $4,982,717.46 | agrar.pl | ||
| Alfachemsp. z o.o. | $3,393,760.50 | alfachem.pl | ||
| Nikwax Europesp. z o.o. | $1,880,501.28 | nikwax.com | ||
| PSH Jurgowiaksp. k. | $1,145,603.49 | psh.com.pl | ||
| Vernimilsp. z o.o. | $563,781.28 | vernimil.com | ||
| Prime Adhesivessp. z o.o. | $357,801.76 | primeadh.pl | ||
| Chmessp. z o.o. | $246,826.85 | chmes.pl | ||
| Chemkraftsp. z o.o. | $15,541.62 | chemkraft.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-08-31 | PKD change (Removed: 102 codes; Added: 9 codes) | |
| 2014-05-27 | Entered in the register |
FAQ
The main business activity of Medipharm International sp. z o.o. sp.k. focuses on wholesale of chemical products.
The company was registered in the Polish National Court Register (KRS) on May 27, 2014.
The headquarters is located at: Emilii Sczanieckiej 20B, 64-316 Kuślin.
The share capital of the company is PLN 6,000 (approx. $1,621).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $167,347, representing an increase of 2.3% compared to 2024.
No, the company recorded a net loss of $4,178 in 2025. For comparison, in 2024 the loss was $24,154, meaning the company reduced its loss by 82.7%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $76,209 in 2025, representing 47% of all operating expenses.
Last updated: 2026-05-29